CCEL
CRYO CELL INTERNATIONAL INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- X Aug 14 Short interest jumps 41.9% to 12.7K
- X Aug 31 Short interest falls 55.5% to 5.7K
- X Sep 15 Short interest jumps 60.0% to 9.1K
- X Sep 30 Short interest falls 29.2% to 6.4K
- E Oct 6 Trading halt: Halt Resumed: CCEL — trading resumed after M (Volatility T…
- E Oct 6 Trading halt: Trading Halt: CCEL — M (Volatility Trading Pause)
- E Oct 9 Earnings: CCEL Q3 2026 Earnings: EPS $0.16 (+422.9% vs est)
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 1 added (0 new), 2 trimmed or exited.
- EstimatesRISING
Current-quarter EPS estimate −$0.130 → $0.050 over 90 days. 1 up, 0 down in 30 days.
- TrendUPTREND
14% above its 50-day average. New closing high $5.01 on Oct 26.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | ADD | $44.9K |
| BlackRock, Inc. | TRIM | $21.4K |
| UBS Group AG | TRIM | $1.0K |
| UBS Group AG | DOUBLED | $2.4K |
| UBS Group AG | ADD | $733.00 |
| CITADEL ADVISORS LLC | TRIM | $52.9K |
| UBS Group AG | ADD | $608.00 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | $14.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Oct 2025| Date | Firm | Rating |
|---|---|---|
| Oct 20, 2025 | Maxim Group DOWNGRADE | Hold |
| Mar 4, 2025 | Maxim Group MAINTAIN | Buy |
| Aug 29, 2022 | Maxim Group INITIATE | Buy |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 5, 2026 | PORTNOY DAVID Chairman, Co-CEO | OTHER | $800.0K |
| May 28, 2026 | TAYMANS JILL M VP Finance, CFO | EXERCISE | $23.3K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.05 | $0.05–$0.05 | -16.7% | $7.4M |
| Next Q | $0.02 | $0.02–$0.02 | — | $7.3M |
| Current FY | $0.11 | $0.11–$0.11 | +37.5% | $30.0M |
| Next FY | $0.02 | $0.02–$0.02 | — | $28.4M |
Short side
FINRA· Oct 15, 2026| Oct 6, 2026 | Volatility Pause | Resumed |
SecBot reports
2 filings · 0 bullish · 1 bearish · 1 neutral- BEARISH DEF 14AOct 13, 2026
Cryo-Cell International filed its definitive proxy statement for the 2026 Annual Meeting…
Watch for the say-on-pay vote result—low approval (<70%) would signal investor discontent with compensation amid a net loss. The activist Camac Partners (6.83% holder) may use the meeting to…
- NEUTRAL 8-KMay 8, 2026
Cryo-Cell International received acceptance of its compliance plan from NYSE American, avoiding…
Monitor Cryo-Cell's quarterly filings for progress on regaining compliance; failure to meet plan milestones could trigger delisting proceedings.
All CCEL filing & press-release reports (2)
- DEF 14A reportOct 13, 2026
- 8-K reportMay 8, 2026